Pharmaceuticals, Biotechnology and Life Sciences
Halozyme Therapeutics said Wednesday that argenx has selected a second target under the collaboration and license agreement the companies announced in February 2019.
Synlogic in clinical collaboration with Roche to explore Synlogic’s Synthetic Biotic medicine for advanced solid tumors
Global Healthcare Strategy Consulting Expert Sheldon Ng Joins Navigant to Bolster Life Sciences and Provider Collaboration
Exicure to Present at TIDES 2019 on Preclinical and Clinical Development of AST-008
Columbia Care and Westmed testing precisely formulated cannabis-based drugs can relieve pain from arthritis
Seattle Genetics has announced the appointment ofRobin G. Taylor, M.B.A., Ph.D., as Chief Commercial Officer
Xcenda,a part of AmerisourceBergen, today announced the acquisition ofDymaxium, a trusted market access partner specializing in the exchangeof evidence and information between payers and life science companiesthrough its FormularyDecisions.com® platform.
DUBLIN–(BUSINESS WIRE)–The “US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025” drug pipelines has been added to…
PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process
The KEYTRUDA breast cancer clinical development program encompassesseveral internal and external collaborative studies, including threeongoing registration-enabling studies in TNBC.